Mtip Ag

MTIP AG is a Swiss-based growth investor specialising in scaling up healthcare-technology (health-tech) companies across rapidly expanding global markets. The firm is based in Basel, Switzerland (home of Novartis, Roche, and the global pharmaceutical industry's European heart), and invests in digitally-connected, decentralised healthcare-technology companies that are post-product-market-fit and entering growth / scale-up stages. MTIP was founded by Christoph Kausch (Founder and Managing Partner; prior healthcare-investment industry executive) alongside partners. The firm has raised multiple institutional funds (MTIP I, II, III) with aggregate AUM in the EUR / CHF several-hundred-million range. MTIP operates across European and U.S. health-tech markets, with particular expertise in digital health, health-services technology, medical-imaging software, and adjacent growth-stage health-tech themes. Notable portfolio companies have included various European and U.S. digital-health / health-tech companies producing multiple exits. Detailed current portfolio disclosures are partially documented in mainstream financial-industry databases for this specific URL.